Lung regeneration : implantation of fetal rat lung fragments into adult rat lung with bleomycine induced fibrosis
Lung regeneration : implantation of fetal rat lung fragments into adult rat lung with bleomycine induced fibrosis
批准号:
17591474
负责人:
SEKIYAMA Syoji
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
我们以前曾报道正常的胎儿肺组织可以在正常成人肺内存活并进一步生长和分化(J Thorac心脏ovasc Surg 2006;131;1148-53)。在本研究中,将正常胎肺组织植入博莱霉素诱导的纤维化成年大鼠肺实质。取GFP-LEW胎肺组织(第17天)作为供体。正常成年大鼠经细导管气管内注射博莱霉素造成肺纤维化。每只大鼠在给药前三天置入导管(气管切开管)。博莱霉素以4.5 mg/kg或3 mg/kg的总剂量分4次给药。对照组大鼠注射生理盐水。第17天将GFP阳性的胎鼠肺组织接种于3周或4周前用博莱霉素组的成年大鼠。为了抑制对GFP抗原的免疫反应,受体大鼠注射环孢素A(10 mg/kg)。从第0天开始隔天,环孢素用量逐渐减少)。分别于植入后1、2、4、8、12周处死受体大鼠。移植胎肺组织的受体肺连续切片,荧光显微镜下观察。苏木精-伊红染色,博莱霉素性肺纤维化肺实质内移植物可存活、生长,并随肺泡开放而分化。
英文摘要
We previously reported that normal fetal lung tissues could survive and further grow and differentiate inside normal adult lung (J Thorac Cardiovasc Surg 2006; 131; 1148-53). In the present study, normal fetal lung tissues were implanted to bleomycine induced fibrotic adult rat lung parenchyma. GFP-LEW fetal lung tissues (day 17) were used as a donor. Normal adult rats were treated with intratracheal administration of bleomycine via a fine catheter to cause a situation of pulmonary fibrosis. A catheter (tracheotomy tube) was implanted in each rat three days before dosing. Bleomycine at a total dose of 4.5mg/kg or 3mg/kg was administered in four divided doses. Saline was administered for control rats.Day 17 fetal rat lungs tissues (GFP positive) in culture medium implanted to adult rats treated with bleomycine 3 or 4 weeks ago. To suppress immune responses to GFP antigen, recipient rats were administrated cyclosporine (10mg/kg i.m. on alternate days from day 0, dose of cyclosporine was decrease gradually). Recipient rats were killed 1, 2, 4, 8, 12 weeks after implantation. Recipient lungs implanted with fetal lung tissues were serially cut and examined under fluorescence microscope. The same specimens were stained with hematoxylin and eosin.The grafts implanted into pulmonary parenchyma with bleomycine induced fibrosis could survive and grow and differentiated with opening of the alveolar space.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
-
批准号:82372007
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:谢文晖
-
依托单位:
基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
-
批准号:82371997
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张春富
-
依托单位:
IL-33调控EOMES+Tr1样细胞分化介导EGFR突变肺癌免疫逃逸的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:周斐
-
依托单位:
脂肪酸合成通过GDF15/IRS2介导胰岛素抵抗促进血管内皮细胞活化导致脓毒症肺损伤的机制研究
-
批准号:82372203
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李然然
-
依托单位:
(11)C标记tariquidar及表达P-糖蛋白的耐药性肺癌PET显像
-
批准号:81101776
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:刘俊
-
依托单位:
非吸烟肺癌表皮生长因子受体基因相关非编码小RNA差异表达研究
-
批准号:81071914
-
项目类别:面上项目
-
资助金额:36.0万元
-
批准年份:2010
-
负责人:钱碧云
-
依托单位:
肢体缺血后适应抑制肺泡巨噬细胞活化及防治肺缺血再灌注损伤机制的研究
-
批准号:81070041
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:甘辉立
-
依托单位:
常山酮增强肺癌放疗效果同时预防放射性肺损伤的分子机制研究
-
批准号:30970864
-
项目类别:面上项目
-
资助金额:29.0万元
-
批准年份:2009
-
负责人:赵路军
-
依托单位:
Endoglin基因修饰肿瘤/DC杂交细胞诱生靶向特异性抗人肺癌CTL疫苗的研究
-
批准号:30760248
-
项目类别:地区科学基金项目
-
资助金额:16.0万元
-
批准年份:2007
-
负责人:周源
-
依托单位:
与肺癌细胞侵袭相关的microRNAs研究
-
批准号:30771187
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2007
-
负责人:罗泽伟
-
依托单位: